A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus
- 1 June 2009
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 136 (7) , 2101-2114.e6
- https://doi.org/10.1053/j.gastro.2009.02.062
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-upGastrointestinal Endoscopy, 2008
- Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veteransGastrointestinal Endoscopy, 2008
- Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancerPublished by Oxford University Press (OUP) ,2007
- Long-Term Survival Following Endoscopic and Surgical Treatment of High-Grade Dysplasia in Barrett’s EsophagusGastroenterology, 2007
- A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term resultsGut, 2006
- Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trialGastrointestinal Endoscopy, 2005
- Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablationBritish Journal of Surgery, 2001
- Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopyGastrointestinal Endoscopy, 1991
- Instrumental perforations of the oesophagus and their management.Thorax, 1988
- Chinese Experience in the Surgical Treatment of Carcinoma of the EsophagusAnnals of Surgery, 1979